Novel tried and tested CSO strategy and model in China – founder pioneered the Novamed model in 2006-2011.
Nuance has secured a leading China based management team.
Founder and core team pioneered the AstraZeneca growth model in 2002 – AZ China is currently the leading Rx MNC in China.
Successfully launched and developed a new model CSO in 2006, Novamed which partnered with leading MNC’s Sanofi, Pfizer and Baxter. Pioneered an unparalleled MNC legacy brand transition and growth model via this new model.
The company is focussed on building hospital and not channel demand – strong record of building hospital demand.
The company employs compliance driven education and promotional model across hospitals and pharmacies in China.
Employs a precise and accurate business intelligence model when implementing commercial plans in China – strong targeting & segmentation platform approach.
Strong business continuity through staff retention and business intelligence.
Compelling commercial and strategic rationale for companies to partner with Nuance.